Haemonetics Corporation (HAE)

Days of sales outstanding (DSO)

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Receivables turnover		6.71	6.48	6.37	6.62	6.34	6.00	7.11	6.88	6.52	6.24	6.32	7.01	6.23	6.15	6.61	6.80	6.82	6.02	6.38	6.70
DSO	days	54.36	56.32	57.26	55.13	57.60	60.81	51.32	53.05	55.95	58.54	57.77	52.10	58.57	59.34	55.23	53.70	53.49	60.68	57.24	54.46

March 31, 2025 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.71
= 54.36

Haemonetics Corporation's Days Sales Outstanding (DSO) has shown fluctuations over the years based on the provided data. DSO represents the average number of days it takes for the company to collect revenue after a sale is made.

The trend indicates that the company's DSO has ranged from a low of 51.32 days on September 30, 2023, to a high of 60.81 days on December 31, 2023. This suggests variations in the efficiency of the company in collecting payments from customers.

The DSO values have generally been within a relatively narrow range, indicating that Haemonetics Corporation has been fairly consistent in its collection processes. However, it is important for the company to monitor and manage its DSO efficiently to ensure timely collection of receivables and maintain healthy cash flow.

The company should aim to keep its DSO at an optimal level to maximize liquidity and operational efficiency. Any significant deviations from historical averages should be carefully analyzed to identify any underlying issues in the company's credit and collection policies.